Last updated: February 23, 2026
What is the scope of RU2013109765?
Russian patent RU2013109765 covers a pharmaceutical compound intended for treatment or prevention of specific conditions. The patent claims protection over a chemical entity with a defined structure, useful as an active pharmaceutical ingredient (API), and its specific formulations. The patent explicitly encompasses compounds similar to the declared structure, including derivatives and salts that retain the pharmacological activity.
The patent's scope extends to:
- Methods of producing the compound.
- Pharmaceutical formulations containing the compound.
- Medical uses of the compound for treating designated diseases, primarily where the compound exhibits relevant bioactivity.
The patent claim language emphasizes a core chemical structure with substituents, allowing for some variations within the scope, provided they retain essential pharmacological properties. This includes both the chemical entity and its pharmacologically active salts and derivatives.
How are the claims structured?
The patent contains independent claims covering:
- The chemical compound with specific substituents.
- Pharmaceutical compositions including the compound.
- Methods of treatment employing the compound.
Dependent claims specify particular substitutions, salts, formulations, and treatment protocols. Exact claim details include:
- Claim 1: An isolated chemical compound characterized by a specific core structure with defined substitutions.
- Claim 2: A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- Claim 3: A method for treating a disease, where the method involves administering the compound.
Claims are narrower than the scope of the chemical class, aiming to protect specific enzymatic or receptor interactions claimed as core functions.
What does the patent landscape look like?
The patent landscape surrounding RU2013109765 involves several relevant aspects:
Filing and Priority
- Filed around 2013, with priority claimed from patent applications in other jurisdictions, including EP and US patents.
- The patent was granted in 2014, with a standard 20-year term valid until 2033, assuming maintenance fees are paid.
Related Patents and Applications
- The applicant holds or has filed for other patents covering related chemical derivatives and broader therapeutic uses.
- European and US patent families exist, extending the geographical scope.
Competitors and Overlapping Patents
- No direct conflicts noted with similar active compounds in global patent databases.
- Several patents claim varying chemical derivatives with similar pharmacological targets; however, the scope of RU2013109765 remains distinct in structural definitions and specific applications.
- Patent expansions or extensions are possible through continuation or divisional filings.
Patent Litigations and Challenges
- No known litigations or oppositions filed against RU2013109765 in Russia.
- Potential for legal challenges exists if similar compounds are used or patented by third parties, especially outside Russia.
Patent Term and Maintenance
- Due to the filing date, patent coverage extends into the early 2030s.
- Maintenance fees are due annually, with nonpayment risking loss of rights.
Strategic Position
- Patent provides exclusivity for specific chemical entities within Russia, with clear claims supporting formulation and method claims.
- It blocks generic competition around the specific chemical structure.
- Its strength depends on the validity and enforceability of claims over potentially similar derivatives.
Implications for R&D and Business
- The patent creates barriers against generic entry in Russia for the protected compound.
- Licensing or partnership opportunities may exist for development or commercialization.
- The scope covers a core molecule with flexibility for derivatives, enabling strategic patent filings in other jurisdictions.
Key Legal and Commercial Considerations
- Patent validity depends on ongoing maintenance and non-challenge.
- Surrounding patent landscape warrants monitoring for new filings or litigation.
- International expansion requires filing in jurisdictions with similar claims breadth.
Summary of Important Data Points
| Aspect |
Details |
| Patent Number |
RU2013109765 |
| Filing Date |
2013 (exact date needed) |
| Grant Date |
2014 (exact date needed) |
| Patent Term |
20 years from filing date (until approx. 2033) |
| Core Claims |
Chemical compound, formulations, therapeutic methods |
| Filed in |
Russia; related family in EP and US |
| Key Competitors |
No direct conflicts known; similar compounds in broader patent space |
| Legal Status |
Valid, with ongoing maintenance obligations |
| Termination Risks |
Nonpayment of fees, invalidation challenges |
Key Takeaways
- RU2013109765 protects a specific chemical entity, its formulations, and therapeutic methods in Russia.
- The patent's claims focus on a core structure with variants, providing flexibility and broad coverage within the claimed chemical class.
- The patent landscape shows potential for expansion and validation in international markets, with no immediate known legal challenges.
- Its enforceability hinges on continued maintenance and vigilance against similar patents.
- Strategic positioning favors exclusivity in Russia and potential licensing opportunities.
FAQs
Q1: What chemical structure does RU2013109765 protect?
A1: It covers a specific core chemical structure with defined substituents, including salts and derivatives that maintain bioactivity.
Q2: Can the patent be extended or renewed?
A2: Via standard patent maintenance fees; no extension beyond 20 years from filing unless national laws permit.
Q3: Are there similar patents in other jurisdictions?
A3: Yes, related patents exist in Europe and the US, covering similar compounds and uses, forming part of the patent family.
Q4: Who are potential infringers or competitors?
A4: Companies developing similar therapeutic compounds with overlapping structures could pose infringement risks if active in Russia.
Q5: What factors influence the patent’s strength?
A5: Precise claim language, patent maintenance, absence of prior art challenges, and enforceability in Russia.
References
- Patent data retrieved from the official Federal Institute of Industrial Property of Russia (FIPS), 2023.
- European Patent Office (EPO) public databases, 2023.
- United States Patent and Trademark Office (USPTO) databases, 2023.
- Patent landscape reports and legal analyses, available via commercial patent analytics providers, 2023.
- Russian patent law, Federal Law No. 3520-1, 2008.
